Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5W0X

Crystal structure of mouse TOR signaling pathway regulator-like (TIPRL) delta 94-103

Summary for 5W0X
Entry DOI10.2210/pdb5w0x/pdb
DescriptorTIP41-like protein (2 entities in total)
Functional Keywordsbutterfly-like fold protein phosphotase 2a regulator, signaling protein
Biological sourceMus musculus (Mouse)
Total number of polymer chains1
Total formula weight28190.97
Authors
Wu, C.,Zheng, A.,Li, J.,Satyshur, K.,Xing, Y. (deposition date: 2017-06-01, release date: 2018-01-17, Last modification date: 2024-10-23)
Primary citationWu, C.G.,Zheng, A.,Jiang, L.,Rowse, M.,Stanevich, V.,Chen, H.,Li, Y.,Satyshur, K.A.,Johnson, B.,Gu, T.J.,Liu, Z.,Xing, Y.
Methylation-regulated decommissioning of multimeric PP2A complexes.
Nat Commun, 8:2272-2272, 2017
Cited by
PubMed Abstract: Dynamic assembly/disassembly of signaling complexes are crucial for cellular functions. Specialized latency and activation chaperones control the biogenesis of protein phosphatase 2A (PP2A) holoenzymes that contain a common scaffold and catalytic subunits and a variable regulatory subunit. Here we show that the butterfly-shaped TIPRL (TOR signaling pathway regulator) makes highly integrative multibranching contacts with the PP2A catalytic subunit, selective for the unmethylated tail and perturbing/inactivating the phosphatase active site. TIPRL also makes unusual wobble contacts with the scaffold subunit, allowing TIPRL, but not the overlapping regulatory subunits, to tolerate disease-associated PP2A mutations, resulting in reduced holoenzyme assembly and enhanced inactivation of mutant PP2A. Strikingly, TIPRL and the latency chaperone, α4, coordinate to disassemble active holoenzymes into latent PP2A, strictly controlled by methylation. Our study reveals a mechanism for methylation-responsive inactivation and holoenzyme disassembly, illustrating the complexity of regulation/signaling, dynamic complex disassembly, and disease mutations in cancer and intellectual disability.
PubMed: 29273778
DOI: 10.1038/s41467-017-02405-3
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.717 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon